Stay updated on Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Sign up to get notified when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision history updated from v3.4.1 to v3.4.2; no user-facing content or functional changes are evident.
    Difference
    0.1%
    Check dated 2026-02-13T16:54:06.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no study content or data appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:32:25.000Z thumbnail image
  4. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.1%
    Check dated 2026-02-05T13:31:35.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    Added UI and metadata changes including a glossary toggle, a new 'Last Update Submitted that Met QC Criteria' label, and a page revision indicator ('Revision: v3.4.0'), while removing the older QC label and the 'No FEAR Act Data' entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-29T06:36:21.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed on the page, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-15T03:46:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page’s Locations section was updated to add Maryland and Victoria as locations and reorganize the location blocks. The HHS Vulnerability Disclosure link was removed and the revision label updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-24T15:35:18.000Z thumbnail image

Stay in the know with updates to Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.